AKT1 and breast carcinoma: BMP-9 inhibits the proliferation and metastasis of SK-BR-3 breast cancer cells via decreasing HER2 expression and inactivating ERK1/2 and PI3K/AKT signalling pathways (Ren et al. 2014a).